324 filings
Page 2 of 17
8-K
6km22j4i9id6homtpf
22 Feb 23
Entry into a Material Definitive Agreement
5:29pm
8-K
rjqce2mz g1
26 Jan 23
Departure of Directors or Certain Officers
4:31pm
8-K
i8bgjy7ryq9ny4
10 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
t54egplyocybkq ojx2p
4 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:35am
8-K
r9h020led4
6 Dec 22
Termination of a Material Definitive Agreement
4:30pm
8-K
luj8 2lmo
5 Dec 22
Entry into a Material Definitive Agreement
6:02am
8-K
u16wx nwefv
25 Nov 22
Entry into a Material Definitive Agreement
6:01am
8-K
5v3zrtl2wi
23 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:15am
8-K
ijxrp
22 Nov 22
Entry into a Material Definitive Agreement
4:06pm
8-K
eteb4084k7
9 Nov 22
Regulation FD Disclosure
4:31pm
8-K
13ul2 rwbordupy
24 Oct 22
Entry into a Material Definitive Agreement
4:31pm
8-K
orbetix
14 Oct 22
Entry into a Material Definitive Agreement
4:33pm
8-K
i2sea9g3nv4pau erp5j
11 Oct 22
Amendments to Articles of Incorporation or Bylaws
8:30am
8-K
b0vunahf5xvc9ck 84i7
23 Sep 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
kp6muyhchit
15 Sep 22
Entry into a Material Definitive Agreement
4:30pm
8-K/A
ox5 xwzrldzj9
1 Sep 22
Departure of Directors or Certain Officers
4:45pm
8-K
fv2gd xkf
5 Aug 22
Departure of Directors or Certain Officers
4:32pm
8-K
je4nyg
27 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
spqmotkf d48u
1 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
f0c3qz8z
17 Jun 22
Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
5:21pm